Assessment of Macular Function by Multifocal Electroretinogram in Patients with Multiple Sclerosis Treated with Fingolimod

ConclusionsOur mfERG results suggest that the chronic use of FTY does not induce a dysfunction of pre-ganglionic retinal elements located in the 0 –25° of central retina. Since FTY does not cause any retinal functional abnormality, we suggest that FTY treatment could not produce any toxic effect on pre-ganglionic retinal elements even in the absence of macular oedema.

http://link.springer.com/10.1007/s12325-021-01728-4

Source: Advances in Therapy - June 9, 2021 Category: Drugs & Pharmacology Source Type: research